Meihua Sui

5.1k total citations · 2 hit papers
73 papers, 4.3k citations indexed

About

Meihua Sui is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Meihua Sui has authored 73 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 24 papers in Biomaterials and 22 papers in Oncology. Recurrent topics in Meihua Sui's work include Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (17 papers) and Dendrimers and Hyperbranched Polymers (14 papers). Meihua Sui is often cited by papers focused on Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (17 papers) and Dendrimers and Hyperbranched Polymers (14 papers). Meihua Sui collaborates with scholars based in China, United States and New Zealand. Meihua Sui's co-authors include Youqing Shen, Jianbin Tang, Weiwei Mao, Jinqiang Wang, Weimin Fan, Weilin Sun, William J. Murdoch, Jianbin Tang, Erlei Jin and Dongsheng Huang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.

In The Last Decade

Meihua Sui

72 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment

2015 572 citations Jinqiang Wang, Weiwei Mao et al. profile →
Prodrugs Forming High Drug Loading Multifunctional Nanocapsules for Intracellular Cancer Drug Delivery

2010 524 citations Youqing Shen, Erlei Jin et al. profile →

Peers

Countries citing papers authored by Meihua Sui

Since Specialization

Citations

This map shows the geographic impact of Meihua Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meihua Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meihua Sui more than expected).

Fields of papers citing papers by Meihua Sui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meihua Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meihua Sui. The network helps show where Meihua Sui may publish in the future.

Co-authorship network of co-authors of Meihua Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Meihua Sui. A scholar is included among the top collaborators of Meihua Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meihua Sui. Meihua Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating cell cycle- and autophagy-associated cellular accumulation of lipid-based nanoparticles 2025 ·Nature Communications ·(unknown), Gan Luo, (unknown), (unknown), Xiao Xu, (unknown), (unknown), (unknown), (unknown), Ying Jin, Meihua Sui	0
2	PRODH safeguards human naive pluripotency by limiting mitochondrial oxidative phosphorylation and reactive oxygen species production 2024 ·EMBO Reports ·(unknown), (unknown), Wenjie Chen, Zhiyuan Gong, Bo Kang, Meihua Sui, (unknown), Yingjie Wang	3
3	Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats 2023 ·npj Vaccines ·(unknown), (unknown), Changzheng Yuan, Xiao Xu, (unknown), Yu-Hui Huang, Huan Lu, (unknown), Gan Luo, (unknown), Meihua Sui	59
4	Intestinal microecology in mice bearing diethylnitrosamine-induced primary hepatocellular carcinoma 2022 ·Journal of Zhejiang University (Medical Sciences) ·(unknown), Yue Zheng, Jia Shang, Haiyang Wang, (unknown), Huan Lu, Xiaoxi Wang, Meihua Sui	4
5	Lipid Metabolism in Tumor-Associated Natural Killer Cells 2021 ·Advances in experimental medicine and biology ·(unknown), Meihua Sui	15
6	Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities 2019 ·Frontiers in Immunology ·Weilei Hu, Guosheng Wang, Dongsheng Huang, Meihua Sui, Yibing Xu	294
7	Paclitaxel improved gene transfection efficiency through cell synchronization in SW480 cells 2015 ·Journal of Controlled Release ·Nasha Qiu, Xiangrui Liu, Meihua Sui, Jianbin Tang, Youqing Shen	4
8	A tumor-targeting MRI contrast agent based on hypoxia and pH-responsive nanogel 2015 ·Journal of Controlled Release ·Tianyu Wang, Qi Zeng, Jianbin Tang, Meihua Sui, Xiangrui Liu, Youqing Shen	1
9	Amphiphilic block copolymer of SN38 prodrugs by atom transfer radical polymerization: Synthesis, kinetic studies and self-assembly 2015 ·Journal of Controlled Release ·Xun Liu, Jinqiang Wang, Youqing Shen, Jianbin Tang, Meihua Sui	5
10	Jellyfish-Shaped Amphiphilic Dendrimers: Synthesis and Formation of Extremely Uniform Aggregates 2014 ·Macromolecules ·Shiqun Shao, Jingxing Si, Jianbin Tang, Meihua Sui, Youqing Shen	32
11	Tumor Redox Heterogeneity‐Responsive Prodrug Nanocapsules for Cancer Chemotherapy 2013 ·Advanced Materials ·Jinqiang Wang, Xuanrong Sun, Weiwei Mao, Weilin Sun, Jianbin Tang, Meihua Sui, Youqing Shen, Zhongwei Gu	354
12	Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging 2013 ·Journal of Controlled Release ·Mingzhou Ye, Yue Qian, Jianbin Tang, Hongjie Hu, Meihua Sui, Youqing Shen	59
13	Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery 2013 ·Biomaterials ·Zhuxian Zhou, Xinpeng Ma, Erlei Jin, Jianbin Tang, Meihua Sui, Youqing Shen, Edward A. Van Kirk, William J. Murdoch, Maciej Radosz	156
14	Degradable Dual pH‐ and Temperature‐Responsive Photoluminescent Dendrimers 2011 ·Chemistry - A European Journal ·Youqing Shen, Xinpeng Ma, Bo Zhang, Zhuxian Zhou, Qihang Sun, Erlei Jin, Meihua Sui, Jianbin Tang, Jinqiang Wang, Maohong Fan	60
15	Platinum (IV)-coordinate polymers for cancer drug delivery 2011 ·Journal of Controlled Release ·Jun Yang, Weiwei Mao, Meihua Sui, Jianbin Tang, Youqing Shen	5
16	Degradable water soluble hyperbranched polymers for drug delivery 2011 ·Journal of Controlled Release ·Xingping Wang, Jianbin Tang, Meihua Sui, Xinping Wang, Jinxia Xu, Youqing Shen	8
17	Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of β-tubulin at Cys 12 and suppression of microtubule dynamics 2009 ·Molecular Cancer Therapeutics ·Wanhong Xu, Brian Xi, Jieying Wu, Haoyun An, Jenny Zhu, Yama Abassi, Stuart C. Feinstein, (unknown), (unknown), (unknown), Weimin Fan, Meihua Sui, Xiaobo Wang, Xiao Xu	22
18	Parthenolide inhibits proliferation of vascular smooth muscle cells through induction of G0/G1 phase cell cycle arrest 2009 ·Journal of Zhejiang University SCIENCE B ·(unknown), Meihua Sui, Shan Chen, Jianan Wang, Geng Xu, (unknown), Shan Jiang, Lu Fang	14
19	Mining novel biomarkers for prognosis of gastric cancer with serum proteomics 2009 ·Journal of Experimental & Clinical Cancer Research ·Fuming Qiu, Jiekai Yu, Yiding Chen, Qifeng Jin, Meihua Sui, Jian Huang	18
20	Combination of γ-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Meihua Sui, Weimin Fan	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact